Surgery Partners, Inc. (SGRY)

Market Cap	2.64B
Revenue (ttm)	2.99B
Net Income (ttm)	-60.60M
Shares Out	126.38M
EPS (ttm)	-0.48
PE Ratio	n/a
Forward PE	22.91
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120,526
Open	20.83
Previous Close	21.22
Day's Range	20.60 - 21.07
52-Week Range	19.50 - 35.30
Beta	2.58
Analysts	Buy
Price Target	37.38 (+78.68%)
Earnings Date	Nov 12, 2024

About SGRY

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty phy...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 1, 2015
• Employees: 13,500
• Stock Exchange: NASDAQ
• Ticker Symbol: SGRY
• Website: https://www.surgerypartners.com

Financial Performance

In 2023, Surgery Partners's revenue was $2.74 billion, an increase of 8.03% compared to the previous year's $2.54 billion. Losses were -$11.90 million, -78.21% less than in 2022.

Analyst Forecast

According to 9 analysts, the average rating for SGRY stock is "Buy." The 12-month stock price forecast is $37.38, which is an increase of 78.68% from the latest price.

Price Target

$37.38

(78.68% upside)

Analyst Consensus: Buy